Janus Henderson Group plc 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 2:57 pm Purchase | 2024-09-30 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 4,186,694 7.000% | 191,909 (+4.80%) | Filing |
2024-02-13 11:57 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,994,785 6.900% | 350,830 (+9.63%) | Filing |
2023-02-10 10:01 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,643,955 6.400% | 423,990 (+13.17%) | Filing |
2022-02-10 2:12 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,219,965 5.700% | 211,136 (+7.02%) | Filing |
2021-02-12 3:00 pm Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,008,829 5.600% | 3,008,829 (New Position) | Filing |